All Type of News
Dong-A to hit by drug price cut
Dong-A Pharmaceutical could lose up to 19 billion won in sales if the price of Stillen is reduced by 20 percent.
The Health Insurance Review Assessment and Service has recently announced that the insurance prices o...
Daewoong, Binex to join forces in R&D
Daewoong Pharmaceutical and Binex Co. have agreed to join hands to jointly develop new rheumatoid arthritis drug and biosimilars so that the two companies can stay competitive at home and abroad.
The two companies ...
HanAll to initiate Phase I study for oral human growth hormone
HanAll BioPharma said Monday that the Korea Food and Drug Administration approved the first clinical trial for oral human growth hormone (codename: HL-032).
The company plans to conduct its Phase I trial for HL-032...
Ilyang generous with dividends
Ilyang Pharmaceutical was the most generous in offering dividend rewards among the 55 local pharmaceutical firms in 2010, according to Yakup. com., an information provider.
Ilyang topped the list by paying out 70 p...
Dual punishment perplexes drug companies’ salespeople
Last November the Ministry of Health and Welfare launched a crackdown on unlawful drug marketing activities. It introduced a rule which slashes the price of a drug by up to 20 percent if its producer is found to have ...
Korea to launch 2011 economic survey
The nationwide economic consensus will be conducted between May 23 and June 24 for the first time in Korea as part of efforts to identify the main economic challenges faced by this country and analyses policy options ...
Migraine patients double in 4 years
The National Health Insurance Corporation (NHIC) said recently that the number of patients being treated for migraine has almost doubled over the past four years.
The number of patients suffering from severe heada...
Dong-A, GSK gear up cooperation in healthcare sector
Dong-A Pharmaceutical said it will co-market GlaxoSmithKline (GSK)’s Polident and Sendodyne from June, while GSK will co-promote Dong-A’s Garglin in department stores.
Analysts are expecting Dong-A’s partnership wi...
Seven drugmakers to face price cut measures
A total of seven pharmaceutical firms, who were found to provide illegal rebate or kickbacks, will be subject to disciplinary action.
The Health Insurance Review Assessment and Service said Thursday that the author...
Takeda Korea’s sales policy ignites controversy
Local wholesalers are furious at CJ CheilJedang’s attitude as the latter did not inform them of any notice over Takeda Korea’s sales policy.
Wholesalers claimed that CJ failed to inform them of any notice on the ch...
